Avaya Receives Frost & Sullivan's 2017 Market Leadership

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
525
Avaya Receives Frost & Sullivan's 2017 Market Leadership Award for Contact Center Systems in North America

SANTA CLARA, CA --(Marketwired - December 07, 2017) - Avaya today announced it has received the Frost & Sullivan 2017 Market Leadership Award for Contact Center Systems in North America. The award was given to Avaya for its superior leadership and customer service as well as the strategic product development and technological innovation of its Customer Engagement Solutions portfolio, following an extensive, independent evaluation against a number of criteria.

Read Frost & Sullivan's report on Avaya's 2017 Market Leadership award

Avaya's Customer Engagement Solutions portfolio includes its flagship omnichannel customer experience solution, Avaya Oceana. As a flexible, secure foundation, Avaya Oceana delivers context-driven, fully integrated and customizable customer engagement capabilities that allow ongoing transformation with minimal disruption.

The Frost & Sullivan report identified the challenges companies have faced in adapting their customer service strategies to ever-changing business environments, demographics, and technological developments. Customer expectations of an omnichannel experience today need to combine a variety of channels -- including social, mobile, online self and assisted service -- with efficient data capture, analysis and access, plus integrate with multiple business and communications applications to deliver a seamless customer journey. Further, businesses can be at any stage of developing an omnichannel strategy, housing a wide range of systems and applications of various age and capacity to bring in new capabilities.

According to Frost & Sullivan, the ability to bring companies forward from any stage is one of the reasons why Avaya has been in a leadership position for years:

"As the call center went through the evolution from its initial core systems, i.e. ACD and IVR, Avaya has acted as a trusted partner to its growing installed base, by being attuned to the needs of customers and consumers alike, no matter where they are in the journey from point solutions to digital transformation. Integration of disparate applications is a critical success factor for companies achieving omnichannel excellence. Avaya assists customers, during any part of this transformation, by providing the building blocks they need to get there."

This ability to continually help companies adopt new capabilities to improve or expand the customer experience while leveraging existing infrastructure also extends to Avaya's approach to Cloud-based contact center solutions (CCaaS ). The Frost & Sullivan report notes that while many vendors offering CCaaS promote an "all-in-one" solution suite, they sometimes fail to recognize that every organization is at a different stage and may not want to adopt a rip-and-replace strategy. Avaya, however, offers a highly flexible path to cloud, such as enabling a hybrid model for new applications, particular locations or business strategies, as well as public or private cloud options, in addition to on-premises deployments.

Comprehensive Pain Specialists , for example, moved from a barely functioning contact center, equipped by other vendors, to the Avaya Customer Engagement Cloud, supporting 12 locations. The company experienced immediate improvements in functionality and reporting, avoided a costly data center buildout and gained the capacity to support its ambitious growth plans. The flexible, new solution was cost-neutral to what the company was paying before implementing Avaya's CCaaS solution.

Frost & Sullivan noted a number of additional factors leading to Avaya's award under various criteria, including Customer Purchase and Ownership Experience, Technology Leverage and Implementation Excellence, Brand Strength and Growth Strategy Excellence.

In its conclusion for the award, Frost & Sullivan said:

"Avaya remains a stalwart leader in customer contact, with an enviable portfolio of products and partner offers, backed by solid consulting and professional services support. Avaya has achieved a leadership position in the Contact Center Systems market, with a market share of 17.4%. With its strong overall performance and Frost & Sullivan is proud to present to Avaya, the 2017 Market Leadership Award for Contact Center Systems in North America."

"Avaya works closely with our customers to understand the evolution of the customer journey from multiple points of view. While the end customer experience is critical, we can deliver even more business value by understanding how agents, sales and marketing and IT, as well as market and business dynamics, contribute to that experience. This holistic approach places us light years beyond the pop-up providers with limited life spans or the ability to scale their solutions. This is why we are so very pleased that Frost & Sullivan has once again recognized Avaya's leadership in contact center solutions."

Laurent Philonenko, SVP and GM, Solutions and Technology, Avaya

To read case studies of companies of all sizes around the world that trust Avaya to help them deliver a phenomenal customer experience, go here .

About Avaya Avaya enables the mission critical, real-time communication applications of the world's most important operations. As the global leader in delivering superior communications experiences, Avaya provides the most complete portfolio of software and services for contact center and unified communications -- offered on premises, in the cloud, or a hybrid. Today's digital world requires some form of communications enablement, and no other company is better positioned to do this than Avaya. For more information, please visit www.avaya.com .

Follow Avaya on Twitter , Facebook , YouTube , LinkedIn , Flickr and the Avaya Connected Blog .

Source: Avaya Newsroom

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 363

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 387

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 544

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 109

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 305

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 161

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 411

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 174

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 277

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Breakthroughs in Lung Cancer Treatment with Reqorsa

Updated Category News Views 182

Innovative Advances in Lung Cancer Treatment The fight against lung cancer continues to evolve, showcasing promising advancements that bring new hope to patients. Genprex, Inc. is at the forefront of this battle with its revolutionary gene therapy known as Reqorsa. This cutting-edge treatment has been developed specifically to target KRAS mutation in non-small cell lung...

Continue Reading
EfTEN United Property Fund Reports October Earnings and NAV

Updated Category News Views 192

Insights into EfTEN United Property Fund's Recent Performance EfTEN United Property Fund demonstrated a net profit of 110 thousand euros for October, totaling 2.214 million euros for the first ten months of the year, marking a significant improvement from 724 thousand euros during the same period last year. This impressive financial outcome led to a distribution to...

Continue Reading
Cardiff Oncology Reports Encouraging Results in mCRC Trial

Updated Category News Views 236

Cardiff Oncology Reveals Promising Clinical Trial Results Cardiff Oncology, Inc. (Nasdaq: CRDF), a pioneering clinical-stage biotechnology company, has recently announced encouraging results from its ongoing CRDF-004 clinical trial. This randomized Phase 2 trial is investigating the effects of onvansertib in patients suffering from first-line RAS-mutated metastatic...

Continue Reading
Japan's Growing Casting Polyurethane Market and Its Future

Updated Category News Views 127

Japan's Casting Polyurethane Market: A Rising Force The Japan casting polyurethane market is on the verge of significant transformation, anticipated to elevate from a valuation of US$ 134.74 million to a remarkable US$ 248.24 million by 2033. This growth trajectory highlights a compelling compound annual growth rate (CAGR) of 7.08%, revealing the underlying strength...

Continue Reading
Hudson Technologies Faces Challenges Amid Downgrade by B.Riley

Updated Category News Views 353

B.Riley Downgrades Hudson Technologies Stock In a recent market statement, B.Riley has lowered its outlook on Hudson Technologies (NASDAQ: HDSN), shifting the stock rating from Buy to Neutral. This adjustment comes amidst new growth projections adjusted downwards from +16.6% to +8.5%. The modification in expectations has been linked to ongoing pressures on...

Continue Reading